Insider tradingForm 4
Rapport Therapeutics, Inc. (RAPP) Insider Trading
16 open-market trades reported since Aug 20, 2026: 6 purchases worth $1.66M and 10 sales worth $4.49M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Ramiro Sanchez | Director | 1 | $98K | 0 | $0 |
| Abraham Ceesay | CEO | 0 | $0 | 6 | $1.61M |
| Steven M. Paul | Director | 1 | $974K | 0 | $0 |
| John Maraganore | Director | 1 | $249K | 0 | $0 |
| Wendy B. Young | Director | 1 | $100K | 0 | $0 |
| Paul M. Silva | Director | 1 | $100K | 0 | $0 |
| Troy A. Ignelzi | CFO | 1 | $144K | 0 | $0 |
| Cheryl Gault | COO | 0 | $0 | 1 | $332K |
| Krishnaswamy Yeleswaram | Chief Development Officer | 0 | $0 | 3 | $2.55M |
ADVERTISEMENT
320 × 100 ad slot
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 23 | Ramiro SanchezDirector | ▲ BUY | $98K | |
| Oct 23 | Abraham CeesayCEO | ▼ SELL10b5-1 | $64K | |
| Oct 22 | Steven M. PaulDirector | ▲ BUY | $974K | |
| Oct 22 | John MaraganoreDirector | ▲ BUY | $249K | |
| Oct 22 | Wendy B. YoungDirector | ▲ BUY | $100K | |
| Oct 22 | Paul M. SilvaDirector | ▲ BUY | $100K | |
| Oct 21 | Troy A. IgnelziCFO | ▲ BUY | $144K | |
| Oct 8 | Abraham CeesayCEO | ▼ SELL10b5-1 | $108K | |
| Oct 8 | Abraham CeesayCEO | ▼ SELL10b5-1 | $35K | |
| Oct 1 | Cheryl GaultCOO | ▼ SELL10b5-1 | $332K | |
| Sep 24 | Abraham CeesayCEO | ▼ SELL10b5-1 | $87K | |
| Sep 9 | Abraham CeesayCEO | ▼ SELL10b5-1 | $374K | |
| Aug 26 | Krishnaswamy YeleswaramChief Development Officer | ▼ SELL10b5-1 | $1.87M | |
| Aug 26 | Abraham CeesayCEO | ▼ SELL10b5-1 | $938K | |
| Aug 26 | Krishnaswamy YeleswaramChief Development Officer | ▼ SELL10b5-1 | $658K | |
| Aug 20 | Krishnaswamy YeleswaramChief Development Officer | ▼ SELL10b5-1 | $20K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings